Development Level

Tdark 409 | 6,593
Tbio 19 | 11,651

Disease

Carcinoma 319 | 11,493
diabetes mellitus 71 | 1,728
osteosarcoma 27 | 7,950
medulloblastoma, large-cell 23 | 6,241
ovarian cancer 23 | 8,519
lung cancer 19 | 4,740
psoriasis 16 | 6,694
adult high grade glioma 14 | 3,801
Hemolytic anemia 12 | 77
Kidney cancer 10 | 2,613
atypical teratoid / rhabdoid tumor 8 | 5,112
glioblastoma 7 | 5,792
lung adenocarcinoma 7 | 2,716
lung carcinoma 7 | 2,843
group 3 medulloblastoma 6 | 4,104
non primary Sjogren syndrome sicca 6 | 891
Cataract 21 multiple types 5 | 6
Cataract 3 multiple types 5 | 10
Cataract 37 5 | 5
Cataract 4 multiple types 5 | 14
Cataract 7 5 | 32
Rheumatoid arthritis 5 | 1,191
Anorexia nervosa 4 | 80
Breast cancer 4 | 3,577
Sickle Cell Anemia 4 | 53
Thalassemia 4 | 53
ependymoma 4 | 4,679
interstitial cystitis 4 | 2,312
malignant mesothelioma 4 | 3,232
pancreatic cancer 4 | 2,398
Acquired metabolic disease 3 | 336
Astrocytoma, Pilocytic 3 | 3,081
Malaria 3 | 160
Melanoma 3 | 711
Multiple Sclerosis 3 | 540
Pick disease 3 | 1,894
Pulmonary edema 3 | 17
Skin cancer 3 | 469
Type 1 diabetes mellitus 3 | 109
group 4 medulloblastoma 3 | 1,855
primary pancreatic ductal adenocarcinoma 3 | 1,108
primitive neuroectodermal tumor 3 | 3,035
Beta thalassemia 2 | 16
Cardiovascular system disease 2 | 246
Chronic obstructive pulmonary disease 2 | 184
Depressive disorder 2 | 409
Infertility 2 | 188
Juvenile rheumatoid arthritis 2 | 111
Liver Cirrhosis, Experimental 2 | 769
Liver cancer 2 | 604
Major Depressive Disorder 2 | 301
Multiple myeloma 2 | 1,332
Neurodegenerative disease 2 | 414
Paraplegia 2 | 74
Peripheral vascular disease 2 | 87
Prostate cancer 2 | 175
Retinitis Pigmentosa 2 | 226
colon cancer 2 | 1,478
cystic fibrosis 2 | 1,695
ductal carcinoma in situ 2 | 1,744
hereditary spastic paraplegia 2 | 318
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,954
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,290
juvenile dermatomyositis 2 | 1,187
non diabetic and post-ischemic heart failure 2 | 200
non-small cell lung cancer 2 | 2,890
non-small cell lung carcinoma 2 | 317
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,962
pediatric high grade glioma 2 | 1,064
pituitary cancer 2 | 1,972
sonic hedgehog group medulloblastoma 2 | 467
Amyotrophic lateral sclerosis 1 | 451
Atrophic gastritis 1 | 5
Autistic Disorder 1 | 364
Autosomal recessive congenital ichthyosis 11 1 | 10
Babinski Reflex 1 | 100
Bladder Neoplasm 1 | 112
Chemical and Drug Induced Liver Injury 1 | 195
Colorectal adenoma 1 | 15
Disease of anatomical entity 1 | 32
Distal arthrogryposis 1 | 42
Globe disease 1 | 67
Gout 1 | 104
Hyperreflexia 1 | 209
Influenza 1 | 142
Influenza, Human 1 | 51
Lymphoma 1 | 81
MYELODYSPLASTIC SYNDROME 1 | 53
Mucoepidermoid carcinoma 1 | 26
Narcolepsy 1 | 72
Neuropathy 1 | 261
Pain agnosia 1 | 104
Skin Diseases 1 | 71
Slow progression 1 | 89
Spastic Paraplegia 1 | 42
Spastic gait 1 | 23
Systemic lupus erythematosus 1 | 194
Urinary Bladder Neoplasms 1 | 114
West Syndrome 1 | 28

Tissue

Endocrine System 120 | 18,159
Female tissues 54 | 17,400
Male tissues 51 | 17,142
Blood and immune system 48 | 16,909
Nervous System 37 | 16,725
Digestive Tract 35 | 17,369
Urinary Tract 35 | 16,678
Skin and soft tissues 31 | 17,230
Liver and Pancreas 27 | 16,750
Respiratory system 22 | 16,393
Cardiovascular System 19 | 15,192

Target Family

oGPCR 415 | 421
Non-IDG 13 | 12,091

Reactome Pathway

Olfactory Signaling Pathway 428 | 428
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Olfactory receptor 5H15 OR5H15 Tdark oGPCR 0.00000 35
Olfactory receptor 7D2 OR7D2 Tdark oGPCR 0.00000 2
Olfactory receptor 5B21 OR5B21 Tdark oGPCR 0.00000 4
Olfactory receptor 1A2 OR1A2 Tdark oGPCR -0.35218 1.89 21
Olfactory receptor 2A25 OR2A25 Tdark oGPCR 0.00000 44
Olfactory receptor 5B12 OR5B12 Tdark oGPCR 0.00000 145
Guanine nucleotide-binding protein G(T) subunit gamma-T1 GNGT1 Tbio Non-IDG -1.43842 22.5 61
Receptor expression-enhancing protein 5 REEP5 Tbio Non-IDG -2.38203 219.1 170
Olfactory receptor 7C1 OR7C1 Tdark oGPCR -0.04576 1.13 38
Receptor expression-enhancing protein 2 REEP2 Tdark Non-IDG -0.37718 2.37 159